Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Int Immunopharmacol. 2019 Mar 28;71:277–284. doi: 10.1016/j.intimp.2019.03.046

Figure 6.

Figure 6.

Percentage of CD8+CD25+ (A) and B220+CD40L+ (B) splenocytes following daidzein treatment in NOD females. Mice were maintained on the soy-free diet. VHF = females exposed to vehicle (N=9), DZF=females exposed to daidzein (N=9).